ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes

Yoshihiro Miyasaka; Masafumi Nakamura

doi:10.1245/s10434-019-07857-z

ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes

Yoshihiro Miyasaka
, Masafumi Nakamura

Surgery

Research output: Contribution to journal › Comment/debate › peer-review

2 Citations (Scopus)

Original language	English
Pages (from-to)	739-740
Number of pages	2
Journal	Annals of Surgical Oncology
Volume	26
DOIs	https://doi.org/10.1245/s10434-019-07857-z
Publication status	Published - Dec 1 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Surgery
Oncology

Access to Document

10.1245/s10434-019-07857-z

Cite this

@article{1d4dd9082ca542cf9a67ed7e5a0f061c,

title = "ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes",

author = "Yoshihiro Miyasaka and Masafumi Nakamura",

year = "2019",

month = dec,

day = "1",

doi = "10.1245/s10434-019-07857-z",

language = "English",

volume = "26",

pages = "739--740",

journal = "Annals of Surgical Oncology",

issn = "1068-9265",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - ASO Author Reflections

T2 - Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes

AU - Miyasaka, Yoshihiro

AU - Nakamura, Masafumi

PY - 2019/12/1

Y1 - 2019/12/1

UR - https://www.scopus.com/pages/publications/85075792406

UR - https://www.scopus.com/pages/publications/85075792406#tab=citedBy

U2 - 10.1245/s10434-019-07857-z

DO - 10.1245/s10434-019-07857-z

M3 - Comment/debate

C2 - 31538287

AN - SCOPUS:85075792406

SN - 1068-9265

VL - 26

SP - 739

EP - 740

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

ER -

ASO Author Reflections: Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer on Surgical Outcomes

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this